VIGANO', MAURO
VIGANO', MAURO
DIPARTIMENTO DI SCIENZE MEDICHE (attivo dal 01/01/2000 al 27/04/2012)
3 years of Adefovir and Lamivudine combination therapy minimized the risk of genotypic resistance to ADV in Lam resistant patients
2007 P. Lampertico, M. Viganò, E. Manenti, M. Iavarone, G. Lunghi, E. Del Ninno, M. Colombo
3 years of Adefovir and Lamivudine combination therapy minimized the risk of genotypic resistance to ADV in Lam resistant patients
2007 P. Lampertico, M. Viganò, E. Manenti, M. Iavarone, G. Lunghi, E. Del Ninno, M. Colombo
A non-invasive algorithm accurately predicts advanced fibrosis in hepatitis C : a comparison using histology with internal-external validation
2008 S. Paggi, A. Colli, M. Fraquelli, M. Viganò, P. Del Poggio, C. Facciotto, M. Colombo, G. Ronchi, D. Conte
A response guided approach to peginterferon alfa-2a therapy based on HBsAg levels at weeks 12 and 24 improves response rates in HBeAG-negative, genotype D chronic hepatitis B patients
2011 P. Lampertico, M. Vigano, G.G. Di Costanzo, E. Sagnelli, M. Fasano, V. Di Marco, S. Boninsegna, P. Farci, S.R. Fargion, T. Giuberti, V. Rothe, L. Regep, B. Massetto, F. Facchetti, A. Testa
Accuracy of two new predictive models in assessing fibrosis in chronic hepatitis C (CHC)
2006 S. Paggi, M. Fraquelli, D. Conte, M. Colombo, M. Viganò, C. Facciotto, P. Dal Poggio, A. Cossi
Acute hepatitis following assumption of a herbal remedy
2008 M. Viganò, P. Lampertico, M. Colombo
Add on Adefovir prevents the emergence of ADV resistance in Lamivudine-resistant patients : a 4-year study
2008 P. Lampertico, M. Viganò, E. Manenti, M. Iavarone, M. Colombo
Adefovir added to lamivudine for hepatitis B recurrent infection in refractory B-cell chronic lymphocytic leukemia on prolonged therapy with Campath-1H
2006 A. Cortelezzi, M. Viganò, V.R. Zilioli, N.N. Fantini, M.C. Pasquini, G. Lambertenghi-Deliliers, M. Colombo, P. Lampertico
Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine
2005 P. Lampertico, M. Viganò, E. Manenti, M.A. Iavarone, G. Lunghi, M. Colombo
AISF position paper on HCV in immunocompromised patients
2019 A. Marzano, E. Angelucci, M. Astegiano, C. Baratelli, L. Biancone, P. Bironzo, G. Brancaccio, M.R. Brunetto, R. Bruno, P. Burra, M.G. Cabras, P. Caraceni, C. Chialà, M.G. Clemente, A. Colli, B. Daniele, E. De Gasperi, V. Di Marco, M.C. Ditto, S. Fagiuoli, C. Ferri, G.B. Gaeta, P.A. Grossi, B. Imperatrice, P. Lampertico, F.S. Macaluso, S. Madonia, M. Marignani, C. Mazzarelli, A. Mella, G. Missale, S. Parisi, L. Pasulo, M. Puoti, M. Rendina, D. Ribaldone, G. Rossi, P. Toniutto, A. Tucci, P. Vajro, M. Viganò, R. Volpes, A.L. Zignego, E.G. Giannini, L. Miele, F.P. Russo, S. Petta, S. Bonora, E. Brignardello, A. Busca, G. Cariti, F. Cavallo, M. Conforti, M. Coscia, A. Craxì, D. Curci, S. Cusinato, M. Di Maio, R.D. Valle, E. Fusaro, A. Giacardi, L. Giaccone, M. Lagget, D. Libertucci, R. Minutolo, G. Montrucchio, A. Orlando, L. Orsucci, C. Pasquina, A. Pera, C.L. Peroni, M. Pirisi, P. Racca, F. Riccardini, M. Rizzetto, M. Salizzoni, M. Salomone, G.M. Saracco, L. Scaglione, G. Torre, R. Tozzi, U. Vitolo, G. Verme
Anemia during peginterferon-ribavirin therapy results from both increased suppression of erythroid differentiation and haemolysis
2008 A. Aghemo, L. Ronzoni, M. Rumi, S. Monico, A. Colancecco, P. Grillo, M. Viganò, M.D. Cappellini, M. Colombo
Changes in liver stiffness during entecavir therapy in patients with chronic hepatitis B
2009 M. Viganò, S. Massironi, P. Lampertico, M. Fraquelli, S. Della Valle, P. Del Poggio, D. Conte, M. Colombo
Changes in liver stiffness during entecavir therapy in patients with chronic hepatitis B
2009 M. Viganò, S. Massironi, P. Lampertico, M. Fraquelli, S. Della Valle, P. Del Poggio, D. Conte, M. Colombo
Clinical features and outcomes of hepatocellular carcinoma in Caucasian cirrhotic patients on long-term analogue therapy for hepatitis B
2018 A. Loglio, M. Iavarone, G. Grossi, M. Viganò, M.G. Rumi, F. Facchetti, G. Lunghi, A. Sangiovanni, M. Colombo, P. Lampertico
Clinical implications of HBsAg quantification in patients with chronic hepatitis B
2012 M. Viganò, P. Lampertico
Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine
2004 V. Di Marco, A. Marzano, P. Lampertico, P. Andreone, T. Santantonio, P.L. Almasio, M. Rizzetto, A. Craxì, G. Raimondo, G. Squadrito, A. Spadaro, O. Ferrah, T. Santantonio, G. Pastore, G. Niro, A. Andriulli, G. Stornaiolo, M. Stanzione, G.B. Gaeta, F. Piccinino, A. Marrone, G. Ruggiero, R. Ganga, M. Bernas coni, G. Pilleri, M. Brunetto, B. Coco, F. Bonino, G. Mazzella, F. Lodato, P. Andreone, C. Cursaro, s. Fiorino, A.G. Gramenzi, M. Massari, F. Torre, M. Basso, A. Picciotto, S. Targhetta, P. Burra, V. Ciappina, E. Mazzeffini, R. Bruno, S. Bruno, M. Vigano, M. Iavarone, E. Del Ninno, M. Colombo, A. Casella, M. Sonzogni, G. Colloredo, S. Rossi, M. Puoti, S. Gaia, V. Barbon, M. Lagget
Combination therapy with adefovir dipivoxil (ADV)and lamivudine (LAM) in LAM-resistant patients enlisted for liver transplantation
2006 M. Viganò, V. Mazzaferro, E. Manenti, R. Romito, G. Lunghi, A. Pulvirenti, M. Colombo, P. Lampertico
Combined lamivudine and adefovir dipivoxil treatment allows safe and long-term compath-1H therapy in refractory B-cell chronic lymphocytic leukemia with HBV reactivation
2005 A. Cortelezzi, M. Viganò, V.R. Zilioli, N.N. Fantini, M.C. Pasquini, M. Colombo, G. Lambertenghi Deliliers, P. Lampertico
Concomitant therapy with direct-acting antivirals and chemoimmunotherapy in HCV-associated diffuse large B-cell lymphoma
2018 V. Occhipinti, L. Farina, M. Viganò, M. Capecchi, S. Labanca, I. Fanetti, P. Corradini, M. Rumi
Effectiveness of entecavir for the treatment of NUC-naïve chronic hepatitis B patients : A large multicenter cohort study in clinical practice
2009 P. Lampertico, M. Viganò, F. Facchetti, E. Minola, F. Suter, M. Puoti, M. Brunetto, B. Coco, S.R. Fargion, E. Fatta, P. Del Poggio, M. Pozzi, M. Milanese, G. Colloredo, S. Fagiuoli, L. Pasulo, M.A. Iavarone, M. Colombo